Skip to main content

Table 1 Baseline characteristics of diabetic patients with good and poor glycemic control

From: Impact of glycemic control on the association of endothelial dysfunction and coronary artery disease in patients with type 2 diabetes mellitus

 

Good glycemic control group

(n = 46)

Poor glycemic control group

(n = 56)

P value

Male, n (%)

33 (71.7)

40 (71.4)

0.972

Age, years

61.83 ± 9.34

65.43 ± 6.73

0.026

Body mass index, Kg/m2

28.41 ± 2.59

28.16 ± 2.55

0.622

Cigarette smoking, n (%)

17 (37.0)

22 (56.4)

0.810

Hypertension, n (%)

30 (65.2)

45 (80.4)

0.085

Systolic blood pressure, mm Hg

135.35 ± 19.01

141.77 ± 18.69

0.090

Diastolic blood pressure, mm Hg

74.85 ± 10.69

77.82 ± 12.42

0.204

Fasting blood glucose, mmol/L

6.03 ± 0.81

6.90 ± 2.08

0.009

HbA1c, %

6.53 ± 0.31

8.13 ± 1.29

 < 0.001

Serum creatinine, μmol/L

77.04 ± 15.21

78.70 ± 17.55

0.615

Serum uric acid, μmol/L

345.76 ± 79.73

345.98 ± 82.74

0.989

GFR, mL/min/1.73m2

86.83 ± 14.70

83.29 ± 14.47

0.225

Triglyceride, mmol/L

1.39 ± 0.84

1.92 ± 1.75

0.064

Total cholesterol, mmol/L

3.84 ± 0.88

3.89 ± 1.06

0.810

HDL cholesterol, mmol/L

1.23 ± 0.28

1.14 ± 0.25

0.100

LDL cholesterol, mmol/L

2.25 ± 0.80

2.21 ± 0.74

0.804

Apolipoprotein A, g/L

1.24 ± 0.16

1.17 ± 0.19

0.076

Apolipoprotein B, g/L

0.75 ± 0.33

0.75 ± 0.20

0.975

Lipoprotein (a), g/L

0.25 ± 0.27

0.33 ± 0.35

0.220

hsCRP, mg/L

1.18 (0.47–3.04)

2.16 (1.19 ~ 5.76)

0.002

Presence of CAD, n (%)

17 (37.0)

38 (67.9)

0.002

SYNTAX score

7.28 ± 10.54

15.88 ± 16.36

0.003

Gensini score

15.07 ± 21.03

48.99 ± 48.88

 < 0.001

Medication, n (%)

   

 ACE inhibitors/ARBs

25 (54.3)

27 (48.2)

0.538

 β-blockers

28 (60.9)

40 (71.4)

0.260

 Calcium channel blockers

13 (28.3)

14 (25.0)

0.710

 Statins

43 (93.5)

49 (87.5)

0.312

Flow mediated dilation, %

6.94 ± 2.20

6.03 ± 2.08

0.036

  1. Values are given as mean ± standard deviation (SD), median (25th–75th percentile) or number (percentage)
  2. ACE angiotensin converting enzyme, ARB angiotensin receptor blocker, BUN blood urea nitrogen, CAD coronary artery disease, GFR glomerular filtration rate, HbA1c glycated hemoglobin, HDL high-density lipoprotein, hsCRP high-sensitivity C-reactive protein, LDL low-density lipoprotein